Intelligence Β· Patent portfolio

Chinese Academy of Patents

Full USPTO pharma patent portfolio for Chinese Academy of β€” grant dates, expiration, and drug cross-links.

Patents
335
Expiring ≀24m
3

Quick answer

Chinese Academy of has 335 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 3 expire within 24 months β€” use filters for patent-cliff planning.

Page 1 of 7

  1. US 12427137

    Method for reducing methane production in animal stomach

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 12421269

    SGLT2/DPP4 inhibitor and application thereof

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 12403167

    Phenylethanoid glycoside extract from Acanthus ilicifolius L., preparation method thereof and use as anti-liver injury medicament

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 12397034

    Pharmaceutical composition for promoting neurogenesis and method for promoting neurogenesis and inhibiting senescence of brain neurons

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 12389931

    Oyster peptide with effect of improving sexual function and preparation method thereof

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 12383535

    Hydrogen peroxide-responsive KEAP1-NRF2 ppi inhibitor prodrug, and preparation method therefor

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 12378241

    Pyridine derivative as FGFR and VEGFR dual inhibitors

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 12371434

    MLL1 inhibitors and anti-cancer agents

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 12364671

    Methods of administering vitamin A and lactic acid to gilts

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 12358863

    Nitrogen-containing derivative of substituted phenol hydroxy acid ester, and preparation and use thereof

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 12350270

    Antimalarial agents

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 12343321

    Method for ameliorating or avoiding the adverse effects of exogenous gonadotropins on reproductive performance

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 12343448

    Use of stem cells produced by stem cell generator in treatment of hematopoietic damage

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 12338219

    Antimalarial agents

    Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 12331058

    SHP2 and CDK4/6 dual-target inhibitory compound and pharmaceutical composition containing the same

    Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 12325703

    Fused ring compound as FGFR and VEGFR dual inhibitor

    Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 12324798

    Leonurine nanocomposite hydrogel and preparation methods and applications thereof

    Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 12319729

    Anti-Staphylococcus aureus specific antibody and nucleic acid encoding sequence thereof, and uses of the same

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 12310944

    Selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof, preparation method and use thereof

    Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 12297300

    Hyaluronic acid-based zwitterionic polymer brush, preparation method thereof, and use thereof

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 12291530

    GLP-1R agonist and therapeutic method thereof

    Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 12281164

    Genetically engineered dual-targeting chimeric antigen receptor and use thereof

    Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 12269808

    Amino dithioperacid thioester compound, preparation method therefor, and use thereof

    Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 12251458

    Anti-aging preparation for skin and application thereof

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 12251428

    Hydrogel composition, hydrogel biomedical material, method for facilitating regeneration of bone and manufacturing method of hydrogel composition

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 12234236

    GLP-1R agonist and therapeutic method thereof

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 12226476

    Helper epitope peptide and application thereof

    Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 12226437

    Method for enhancing expression of insulin like growth factor 1 receptor in umbilical cord mesenchymal stem cell expressing IGF1R and method for obtaining multipotent umbilical cord mesenchymal stem cell

    Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 12221414

    Quaternary ammonium salt compound, preparation method therefor and use thereof

    Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 12221483

    Fusion protein and nucleic acid encoding sequence thereof, and uses of the same

    Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 12214021

    Study on lactoferrin regulation of bone formation by means of vitamin D receptor

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 12171864

    Biological self-assembled nanocrystal injection having a lymphatic targeting function and preparation method

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 12144881

    Cosmetic composition containing Ξ±-mangostin, method for preparation, and uses thereof

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. US 12110315

    Fish-derived peptidoglycan recognition protein mutant and application thereof

    Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 12102682

    Injectable photothermal hydrogel based on melanin, preparation method, and application thereof

    Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 12090227

    Method to improve the encapsulation efficiency and physicochemical stability of ginsenosides Rg3 and CK nano-emulsion

    Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 12048317

    Astaxanthin-containing condiment and a preparation method therefor

    Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 12018027

    Macrocyclic derivatives acting as XIa factor inhibitor

    Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 12012454

    Anti-tumor antigen nanobody and nucleic acid encoding sequence thereof, and uses of the same

    Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  40. US 11993603

    Preparation for 6-amino-1H-pyrazolo[3,4-d]pyrimidine-based JAK kinase inhibitor and application thereof

    Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  41. US 11976098

    Cooked millet prolamin peptide for inhibiting alpha-amylase and alpha-glucosidase

    Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  42. US 11970523

    Long-acting oxyntomodulin hybrid peptide, preparation method therefor, and application thereof

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  43. US 11970479

    3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  44. US 11963970

    Preparation method of ginseng composition with high ginsenoside bioavailability

    Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  45. US 11957764

    Protein-type nanoparticles, preparation methods, and application thereof

    Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  46. US 11952402

    Fusion protein containing trail and IgG binding domain and the uses thereof

    Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  47. US 11931337

    Compound antioxidant preparation for reducing the number of somatic cells in a livestock animal and a preparation method and application thereof

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  48. US 11925669

    Chinese herbal medicine composition having a function of reducing uric acid

    Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Chinese Academy of have?

335 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Chinese Academy of patents expire?

3 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory